Tonix Pharmaceuticals Holding Stock

Tonix Pharmaceuticals Holding Employees 2024

Tonix Pharmaceuticals Holding Employees

26

Ticker

TNXP

ISIN

US8902607063

WKN

A2PUSY

In 2024, Tonix Pharmaceuticals Holding employed 26 people, a 0% change from the 26 number of employees in the previous year.

Tonix Pharmaceuticals Holding Aktienanalyse

What does Tonix Pharmaceuticals Holding do?

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company that focuses on researching, developing, and marketing innovative therapies for the treatment of psychiatric, neurological, and immunological disorders. The company was founded in 2007 and is based in New York City. Tonix specializes in developing products for the treatment of post-traumatic stress disorder (PTSD). This is a mental health condition that occurs in individuals who have experienced severe trauma, such as those in war situations or violent acts. Tonix's PTSD therapy is based on the use of the compound TNX-102 SL, a novel sedative that reduces REM sleep disturbances and improves patients' sleep. The company has successfully conducted Phase III trials with this medication and is now working on FDA approval. Tonix is also actively involved in developing medications for the treatment of fibromyalgia, a condition that causes pain, fatigue, and sleep disturbances, as well as migraines. The company is exploring novel compounds such as TNX-201, which target the central nervous system. Tonix has several subsidiaries, including a medical device company based in Israel that specializes in the development of devices for the treatment of sleep disorders and sleep apnea. Tonix's business model is focused on developing innovative therapies for severe chronic illnesses and bringing those products to market. The company collaborates closely with leading research institutions and universities, and its medications are developed based on the latest knowledge in molecular biology and pharmacology, utilizing advanced technologies for research and development. Tonix has long-term agreements with various pharmaceutical companies to support the marketing and distribution of its products. The company also emphasizes collaboration with other companies and research institutions to work together on innovative technologies and therapies. The company is well-funded and has a strong financial foundation that allows it to finance the development of its products. It also relies on support from investors who believe in the company's success. Tonix is a company that specializes in the effective treatment of severe chronic illnesses. It focuses on innovative products, close collaboration with leading research institutions, and a solid financial foundation. The goal of Tonix is to help patients worldwide lead healthy and fulfilling lives. Tonix Pharmaceuticals Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Tonix Pharmaceuticals Holding's Employee Base

Tonix Pharmaceuticals Holding's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Tonix Pharmaceuticals Holding's operational capacity and future potential.

Year-to-Year Comparison

Assessing Tonix Pharmaceuticals Holding's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Tonix Pharmaceuticals Holding's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Tonix Pharmaceuticals Holding’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Tonix Pharmaceuticals Holding stock

How many employees does Tonix Pharmaceuticals Holding have this year?

Tonix Pharmaceuticals Holding has 26 undefined employees this year.

How many employees did Tonix Pharmaceuticals Holding have compared to the previous year?

Compared to the previous year, Tonix Pharmaceuticals Holding had 0% more employees.

What impact did the number of employees have on the company Tonix Pharmaceuticals Holding?

The number of employees has a direct impact on the efficiency and productivity of Tonix Pharmaceuticals Holding. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Tonix Pharmaceuticals Holding?

The number of employees can also have an impact on investors of Tonix Pharmaceuticals Holding, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Tonix Pharmaceuticals Holding affect the company?

An increase in equity of Tonix Pharmaceuticals Holding can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Tonix Pharmaceuticals Holding's equity affect the company?

A reduction in equity of Tonix Pharmaceuticals Holding can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Tonix Pharmaceuticals Holding?

Some factors that can influence the equity of Tonix Pharmaceuticals Holding include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Tonix Pharmaceuticals Holding so important for investors?

The equity of Tonix Pharmaceuticals Holding is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Tonix Pharmaceuticals Holding influence the company?

The number of employees at Tonix Pharmaceuticals Holding can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Tonix Pharmaceuticals Holding evolved in recent years?

In recent years, the number of employees at Tonix Pharmaceuticals Holding has changed by 0.

How many employees does Tonix Pharmaceuticals Holding currently have?

Tonix Pharmaceuticals Holding currently has 26 undefined employees.

Why is the number of employees important for investors of Tonix Pharmaceuticals Holding?

The number of employees is important for investors of Tonix Pharmaceuticals Holding as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Tonix Pharmaceuticals Holding take to change the number of employees?

To change the number of employees, Tonix Pharmaceuticals Holding can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Tonix Pharmaceuticals Holding pay?

Over the past 12 months, Tonix Pharmaceuticals Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tonix Pharmaceuticals Holding is expected to pay a dividend of 0 USD.

What is the dividend yield of Tonix Pharmaceuticals Holding?

The current dividend yield of Tonix Pharmaceuticals Holding is .

When does Tonix Pharmaceuticals Holding pay dividends?

Tonix Pharmaceuticals Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tonix Pharmaceuticals Holding?

Tonix Pharmaceuticals Holding paid dividends every year for the past 0 years.

What is the dividend of Tonix Pharmaceuticals Holding?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tonix Pharmaceuticals Holding located?

Tonix Pharmaceuticals Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tonix Pharmaceuticals Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tonix Pharmaceuticals Holding from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Tonix Pharmaceuticals Holding pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Tonix Pharmaceuticals Holding in the year 2023?

In the year 2023, Tonix Pharmaceuticals Holding distributed 0 USD as dividends.

In which currency does Tonix Pharmaceuticals Holding pay out the dividend?

The dividends of Tonix Pharmaceuticals Holding are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Tonix Pharmaceuticals Holding stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Tonix Pharmaceuticals Holding

Our stock analysis for Tonix Pharmaceuticals Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tonix Pharmaceuticals Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.